FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT AKTIVA OMEGA-DIALKYLALKANSYREDERIVAT
1485269 Pharmaceutical compositions containing acetic acid derivatives LABAZ 12 June 1975 [26 June 1974] 28416/74 Heading ASB [Also in Division C2] Pharmaceutical or veterinary compositions, usable in treating non-human subjects with central neurological disorders, comprise as an active ingredient a...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | fin |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | EYMARD PIERRE LUC BROLL MADELEINE BENOIT-GUYOD JEAN-LOUIS ALAN BOUCHERLE ANDRE LOUIS FERRANDES BERNARD TAILLANDIER GEORGES MARCEL |
| description | 1485269 Pharmaceutical compositions containing acetic acid derivatives LABAZ 12 June 1975 [26 June 1974] 28416/74 Heading ASB [Also in Division C2] Pharmaceutical or veterinary compositions, usable in treating non-human subjects with central neurological disorders, comprise as an active ingredient an acetic acid derivative of formula: where R represents where R, and R 2 may be the same or different and each represent an alkyl group with 1-4 carbon atoms, n is an integer from 1-3 inclusive and R 3 and R 4 , which are identical, each represent a straight chain alkyl radical with 1-4 carbon atoms, in association with a carrier or excipient other than Ordinary tap water or a common organic solvent. Preferred active ingredients are 3-n-propyl hexanoic acid; 4-n-propyl-heptanoic acid, 3-n-butyl heptanoic acid, 3-Methyl-butanoic acid, 3-ethyl-pentanoic acid and 5-n-propyl octanoic acid. The composition is preferably in a unit dosage form for rectal or oral administration. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_FI66834BB</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>FI66834BB</sourcerecordid><originalsourceid>FETCH-epo_espacenet_FI66834BB3</originalsourceid><addsrcrecordid>eNqFikEKwjAQRbNxIdUryFygq0pxOzWTGpKmMhkLXZUicVW0UO-PFdy7-e_B-1slpiU2yBg0wdfBMDZRkLwPNtSAHQgxXukmNjoBdGI7hLahGnNt0bver4Mh9kyaeI2yU5vHOC1p_2OmDobkfMnT_BrSMo_39EzvwdiyPBXHqir-Hj5XfC-i</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT AKTIVA OMEGA-DIALKYLALKANSYREDERIVAT</title><source>esp@cenet</source><creator>EYMARD PIERRE LUC ; BROLL MADELEINE ; BENOIT-GUYOD JEAN-LOUIS ALAN ; BOUCHERLE ANDRE LOUIS ; FERRANDES BERNARD ; TAILLANDIER GEORGES MARCEL</creator><creatorcontrib>EYMARD PIERRE LUC ; BROLL MADELEINE ; BENOIT-GUYOD JEAN-LOUIS ALAN ; BOUCHERLE ANDRE LOUIS ; FERRANDES BERNARD ; TAILLANDIER GEORGES MARCEL</creatorcontrib><description>1485269 Pharmaceutical compositions containing acetic acid derivatives LABAZ 12 June 1975 [26 June 1974] 28416/74 Heading ASB [Also in Division C2] Pharmaceutical or veterinary compositions, usable in treating non-human subjects with central neurological disorders, comprise as an active ingredient an acetic acid derivative of formula: where R represents where R, and R 2 may be the same or different and each represent an alkyl group with 1-4 carbon atoms, n is an integer from 1-3 inclusive and R 3 and R 4 , which are identical, each represent a straight chain alkyl radical with 1-4 carbon atoms, in association with a carrier or excipient other than Ordinary tap water or a common organic solvent. Preferred active ingredients are 3-n-propyl hexanoic acid; 4-n-propyl-heptanoic acid, 3-n-butyl heptanoic acid, 3-Methyl-butanoic acid, 3-ethyl-pentanoic acid and 5-n-propyl octanoic acid. The composition is preferably in a unit dosage form for rectal or oral administration.</description><edition>3</edition><language>fin</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1984</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19840831&DB=EPODOC&CC=FI&NR=66834B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19840831&DB=EPODOC&CC=FI&NR=66834B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>EYMARD PIERRE LUC</creatorcontrib><creatorcontrib>BROLL MADELEINE</creatorcontrib><creatorcontrib>BENOIT-GUYOD JEAN-LOUIS ALAN</creatorcontrib><creatorcontrib>BOUCHERLE ANDRE LOUIS</creatorcontrib><creatorcontrib>FERRANDES BERNARD</creatorcontrib><creatorcontrib>TAILLANDIER GEORGES MARCEL</creatorcontrib><title>FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT AKTIVA OMEGA-DIALKYLALKANSYREDERIVAT</title><description>1485269 Pharmaceutical compositions containing acetic acid derivatives LABAZ 12 June 1975 [26 June 1974] 28416/74 Heading ASB [Also in Division C2] Pharmaceutical or veterinary compositions, usable in treating non-human subjects with central neurological disorders, comprise as an active ingredient an acetic acid derivative of formula: where R represents where R, and R 2 may be the same or different and each represent an alkyl group with 1-4 carbon atoms, n is an integer from 1-3 inclusive and R 3 and R 4 , which are identical, each represent a straight chain alkyl radical with 1-4 carbon atoms, in association with a carrier or excipient other than Ordinary tap water or a common organic solvent. Preferred active ingredients are 3-n-propyl hexanoic acid; 4-n-propyl-heptanoic acid, 3-n-butyl heptanoic acid, 3-Methyl-butanoic acid, 3-ethyl-pentanoic acid and 5-n-propyl octanoic acid. The composition is preferably in a unit dosage form for rectal or oral administration.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1984</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFikEKwjAQRbNxIdUryFygq0pxOzWTGpKmMhkLXZUicVW0UO-PFdy7-e_B-1slpiU2yBg0wdfBMDZRkLwPNtSAHQgxXukmNjoBdGI7hLahGnNt0bver4Mh9kyaeI2yU5vHOC1p_2OmDobkfMnT_BrSMo_39EzvwdiyPBXHqir-Hj5XfC-i</recordid><startdate>19840831</startdate><enddate>19840831</enddate><creator>EYMARD PIERRE LUC</creator><creator>BROLL MADELEINE</creator><creator>BENOIT-GUYOD JEAN-LOUIS ALAN</creator><creator>BOUCHERLE ANDRE LOUIS</creator><creator>FERRANDES BERNARD</creator><creator>TAILLANDIER GEORGES MARCEL</creator><scope>EVB</scope></search><sort><creationdate>19840831</creationdate><title>FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT AKTIVA OMEGA-DIALKYLALKANSYREDERIVAT</title><author>EYMARD PIERRE LUC ; BROLL MADELEINE ; BENOIT-GUYOD JEAN-LOUIS ALAN ; BOUCHERLE ANDRE LOUIS ; FERRANDES BERNARD ; TAILLANDIER GEORGES MARCEL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_FI66834BB3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>fin</language><creationdate>1984</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>EYMARD PIERRE LUC</creatorcontrib><creatorcontrib>BROLL MADELEINE</creatorcontrib><creatorcontrib>BENOIT-GUYOD JEAN-LOUIS ALAN</creatorcontrib><creatorcontrib>BOUCHERLE ANDRE LOUIS</creatorcontrib><creatorcontrib>FERRANDES BERNARD</creatorcontrib><creatorcontrib>TAILLANDIER GEORGES MARCEL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>EYMARD PIERRE LUC</au><au>BROLL MADELEINE</au><au>BENOIT-GUYOD JEAN-LOUIS ALAN</au><au>BOUCHERLE ANDRE LOUIS</au><au>FERRANDES BERNARD</au><au>TAILLANDIER GEORGES MARCEL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT AKTIVA OMEGA-DIALKYLALKANSYREDERIVAT</title><date>1984-08-31</date><risdate>1984</risdate><abstract>1485269 Pharmaceutical compositions containing acetic acid derivatives LABAZ 12 June 1975 [26 June 1974] 28416/74 Heading ASB [Also in Division C2] Pharmaceutical or veterinary compositions, usable in treating non-human subjects with central neurological disorders, comprise as an active ingredient an acetic acid derivative of formula: where R represents where R, and R 2 may be the same or different and each represent an alkyl group with 1-4 carbon atoms, n is an integer from 1-3 inclusive and R 3 and R 4 , which are identical, each represent a straight chain alkyl radical with 1-4 carbon atoms, in association with a carrier or excipient other than Ordinary tap water or a common organic solvent. Preferred active ingredients are 3-n-propyl hexanoic acid; 4-n-propyl-heptanoic acid, 3-n-butyl heptanoic acid, 3-Methyl-butanoic acid, 3-ethyl-pentanoic acid and 5-n-propyl octanoic acid. The composition is preferably in a unit dosage form for rectal or oral administration.</abstract><edition>3</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | fin |
| recordid | cdi_epo_espacenet_FI66834BB |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT AKTIVA OMEGA-DIALKYLALKANSYREDERIVAT |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T12%3A08%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=EYMARD%20PIERRE%20LUC&rft.date=1984-08-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EFI66834BB%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |